These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 29480924

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG.
    Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254
    [Abstract] [Full Text] [Related]

  • 3. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR.
    Arch Dermatol; 2007 Jun 27; 143(6):757-62. PubMed ID: 17576942
    [Abstract] [Full Text] [Related]

  • 4. Intrahepatic cholestasis of pregnancy.
    Pusl T, Beuers U.
    Orphanet J Rare Dis; 2007 May 29; 2():26. PubMed ID: 17535422
    [Abstract] [Full Text] [Related]

  • 5. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011.
    Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.orgSociety for Maternal-Fetal Medicine, 409 12 St. SW, Washington, DC 20024, USA. pubs@smfm.org., Lee RH, Mara Greenberg, Metz TD, Pettker CM.
    Am J Obstet Gynecol; 2021 Feb 29; 224(2):B2-B9. PubMed ID: 33197417
    [Abstract] [Full Text] [Related]

  • 6. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
    J Hepatol; 2021 May 29; 74(5):1087-1096. PubMed ID: 33276032
    [Abstract] [Full Text] [Related]

  • 7. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct 29; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 8. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
    Kawakita T, Parikh LI, Ramsey PS, Huang CC, Zeymo A, Fernandez M, Smith S, Iqbal SN.
    Am J Obstet Gynecol; 2015 Oct 29; 213(4):570.e1-8. PubMed ID: 26071912
    [Abstract] [Full Text] [Related]

  • 9. Ursodeoxycholic acid improves pregnancy outcome in patients with intrahepatic cholestasis during pregnancy: A protocol for systematic review and meta-analysis.
    Wang Y, Peng X, Zhang Y, Yang Q, Xiao Y, Chen Y.
    Medicine (Baltimore); 2021 Jan 29; 100(4):e23627. PubMed ID: 33530164
    [Abstract] [Full Text] [Related]

  • 10. [Clinical practice guidelines of the Team of Experts of the Polish Gynecological Society: management of the intrahepatic cholestasis of pregnancy].
    Leszczyńska-Gorzelak B, Oleszczuk J, Marciniak B, Poreba R, Oszukowski P, Wielgoś M, Czajkowski K, Zespoł Ekspertów Polskiego Towarzystwa Ginekologicznego.
    Ginekol Pol; 2012 Sep 29; 83(9):713-7. PubMed ID: 23342903
    [Abstract] [Full Text] [Related]

  • 11. [Intrahepatic cholestasis of pregnancy: French College of Obstetricians and Gynecologists guidelines for clinical practice].
    Sentilhes L, Sénat MV, Bouchghoul H, Delorme P, Gallot D, Garabedian C, Madar H, Sananès N, Perrotin F, Schmitz T.
    Gynecol Obstet Fertil Senol; 2023 Sep 29; 51(11-12):493-510. PubMed ID: 37806861
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy outcomes and prognostic factors in patients with intrahepatic cholestasis of pregnancy.
    Madazli R, Yuksel MA, Oncul M, Tuten A, Guralp O, Aydin B.
    J Obstet Gynaecol; 2015 May 29; 35(4):358-61. PubMed ID: 25384180
    [Abstract] [Full Text] [Related]

  • 13. [Cholestasis of pregnancy].
    Lorente S, Montoro MA.
    Gastroenterol Hepatol; 2007 Nov 29; 30(9):541-7. PubMed ID: 17980133
    [Abstract] [Full Text] [Related]

  • 14. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines.
    Bicocca MJ, Sperling JD, Chauhan SP.
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec 29; 231():180-187. PubMed ID: 30396107
    [Abstract] [Full Text] [Related]

  • 15. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.
    Yang J, Chen C, Liu M, Zhang S.
    Medicine (Baltimore); 2019 Jul 29; 98(27):e16214. PubMed ID: 31277130
    [Abstract] [Full Text] [Related]

  • 16. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.
    Brites D.
    Ann Hepatol; 2002 Jul 29; 1(1):20-8. PubMed ID: 15114292
    [Abstract] [Full Text] [Related]

  • 17. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG, PITCHES study group.
    Lancet; 2019 Sep 07; 394(10201):849-860. PubMed ID: 31378395
    [Abstract] [Full Text] [Related]

  • 18. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M, Czajkowski K, Smolarczyk R.
    Scand J Gastroenterol; 2016 Jan 07; 51(1):78-85. PubMed ID: 26152830
    [Abstract] [Full Text] [Related]

  • 19. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis.
    Ovadia C, Sajous J, Seed PT, Patel K, Williamson NJ, Attilakos G, Azzaroli F, Bacq Y, Batsry L, Broom K, Brun-Furrer R, Bull L, Chambers J, Cui Y, Ding M, Dixon PH, Estiú MC, Gardiner FW, Geenes V, Grymowicz M, Günaydin B, Hague WM, Haslinger C, Hu Y, Indraccolo U, Juusela A, Kane SC, Kebapcilar A, Kebapcilar L, Kohari K, Kondrackienė J, Koster MPH, Lee RH, Liu X, Locatelli A, Macias RIR, Madazli R, Majewska A, Maksym K, Marathe JA, Morton A, Oudijk MA, Öztekin D, Peek MJ, Shennan AH, Tribe RM, Tripodi V, Türk Özterlemez N, Vasavan T, Wong LFA, Yinon Y, Zhang Q, Zloto K, Marschall HU, Thornton J, Chappell LC, Williamson C.
    Lancet Gastroenterol Hepatol; 2021 Jul 07; 6(7):547-558. PubMed ID: 33915090
    [Abstract] [Full Text] [Related]

  • 20. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.